Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MacularProtect Plus is a high-potency dietary supplement designed to support ocular health and provide comprehensive nutritional coverage. It is specifically formulated based on the findings of the Age-Related Eye Disease Study 2 (AREDS2), incorporating clinical doses of lutein (10 mg), zeaxanthin (2 mg), vitamin C, vitamin E, zinc, and copper. Beyond its primary role in supporting the macula and reducing the risk of progression in patients with intermediate to advanced age-related macular degeneration (AMD), the "Plus" designation indicates the inclusion of a full multivitamin and mineral profile. This integrated approach provides over 30 additional nutrients, including B-vitamins, antioxidants like alpha-lipoic acid and taurine, and essential minerals, eliminating the need for patients to take a separate daily multivitamin. The product is developed and marketed by ScienceBased Health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MacularProtect Plus.